
COVID-19 vaccines, essential for pandemic control, raised concerns about their impact on glycemic control in diabetes patients. A study of 409 type 1 and 2 diabetes patients who received at least one COVID-19 vaccine dose reveals some insights. Most patients experienced mild post-vaccination symptoms. Severe diabetic emergencies were more common in long-standing diabetes cases, with Pfizer vaccine recipients reporting more complications. However, these events affected only a minority, and the vaccine's benefits outweigh the risks. Experts suggest monitoring diabetes patients post-vaccination to ensure their well-being. Overall, COVID-19 vaccines show promise despite some adverse effects on a small subset of individuals.
Like
Save
Share